Molecular biology of neurodegenerative diseases : visions for the future.

Molecular biology of neurodegenerative diseases : visions for the future. Part A /

"Molecular Biology of Neurodegenerative Diseases: Visions for the Future, Volume 168 in the Progress in Molecular Biology and Translational Science series, provides the most topical, informative and exciting monographs available on a wide variety of research topics. The series includes in-depth...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Teplow, David B. (Επιμελητής έκδοσης)
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Amsterdam, The Netherlands : Elsevier Academic Press, 2019.
Έκδοση:First edition.
Σειρά:Progress in molecular biology and translational science ; v. 168.
Θέματα:
Nervous system > Degeneration > Molecular aspects.
Neurogenetics.
Electronic books
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Preface / David B. Teplow
  • Section I: Targetting AD. Chapter One. Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings / Kaj Blennow, Henrik Zetterberg
  • Chapter Two. Tracking down a missing trigger for Alzheimer's disease by mass spectrometric imaging based on brain network analysis / Minako Hoshi
  • Chapter Three. Using mirror-image peptides to enhance robustness and reproducibility in studying the amyloid [beta]-protein / Ariel J. Kuhn, Jevgenij A. Raskatov
  • Section II: Etiology of AD. Chapter Four. In search of pathogenic amyloid [beta]-peptide in familial Alzheimer's disease / Michael S. Wolfe
  • Chapter Five. Biology of splicing in Alzheimer's disease research / Kenichi Nagata, Takashi Saito, Takaomi C. Saido, Takashi Morihara
  • Chapter Six. Acquired cerebral amyloid angiopathy: an emerging concept / Masahito Yamada, Tsuyoshi Hamaguchi, Kenji Sakai
  • Section III: Neuroimmunology of AD. Chapter Seven. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease / Goran Šimić, Ena Španić, Lea Langer Horvat, Patrick R. Hof
  • Chapter Eight. Gut microbiota mediated allostasis prevents stress-induced neuroinflammatory risk factors of Alzheimer's disease / Susan Westfall, Umar Iqbal, Maria Sebastian, Giulio Maria Pasinetti
  • Chapter Nine. Neuroimmune interactions in Alzheimer's disease-New frontier with old challenges? / Stefan Prokop, Virginia M.Y. Lee, John Q. Trojanowski
  • Section IV: AD therapy. Chapter Ten. Alzheimer's therapy development: a few points to consider / Einar M. Sigurdsson
  • Chapter Eleven. The next steps in curing Alzheimer's disease / Fred W. van Leeuwen
  • Chapter Twelve. Future horizons in Alzheimer's disease research / Thomas Wisniewski, Eleanor Drummond
  • Chapter Thirteen. Why delay in effective treatment for Alzheimer's disease and related conditions / Khalid Iqbal, Fei Liu, ChengXin Gong, Chunling Dai, Wen Hu
  • Chapter Fourteen. Restoring synaptic function through multimodal therapeutics / Raul Loera-Valencia, Muhammad-Al-Mustafa Ismail, Per Nilsson, Bengt Winblad
  • Chapter Fifteen. Disease-modifying therapy for proteinopathies: can the exception become the rule? / Gal Bitan
  • Chapter Sixteen. Combination therapy for Alzheimer's disease and related dementias / Martin M. Bednar
  • Section V: Alpha-synucleinopathies. Chapter Seventeen. Can infections trigger alpha-synucleinopathies? / Christopher T. Tulisiak, Gabriela Mercado, Wouter Peelaerts, Lena Brundin, Patrik Brundin
  • Chapter Eighteen. Prion-like propagation of [alpha]-synuclein in neurodegenerative diseases / Airi Tarutani, Masato Hasegawa
  • Section VI: Model systems. Chapter Nineteen. Yeast models of neurodegenerative diseases / Mick F. Tuite.

Παρόμοια τεκμήρια